Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
Vietnam flag Vietnam · Delayed Price · Currency is VND
21,500
-900 (-4.02%)
At close: Jan 30, 2026

HNX:MKV Income Statement

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '19
148,869107,036110,906119,634102,410
Revenue Growth (YoY)
39.08%-3.49%-7.30%16.82%-23.90%
Cost of Revenue
97,20371,10078,67486,60580,112
Gross Profit
51,66535,93732,23233,02922,298
Selling, General & Admin
27,31723,87721,53921,08614,185
Operating Expenses
27,31723,87721,53921,08614,185
Operating Income
24,34912,06010,69311,9428,113
Interest Expense
-4,106-38.53-481.41-1,182-3,891
Interest & Investment Income
886.88428.6285.51247.491.04
Currency Exchange Gain (Loss)
--8.449--
Other Non Operating Income (Expenses)
-2.08-3,245-2,754-3,507-1,721
Pretax Income
21,1279,1977,7527,5022,502
Income Tax Expense
4,2261,8721,5501,598735.25
Net Income
16,9017,3246,2015,9041,767
Net Income to Common
16,9017,3246,2015,9041,767
Net Income Growth
130.75%18.11%5.04%234.10%-
Shares Outstanding (Basic)
5555-
Shares Outstanding (Diluted)
5555-
Shares Change (YoY)
0.01%-0.02%--
EPS (Basic)
3380.001464.861240.291181.00-
EPS (Diluted)
3380.001464.861240.001181.00-
EPS Growth
130.74%18.13%5.00%--
Free Cash Flow
10,5735,59724,4067,03121,909
Free Cash Flow Per Share
2114.581119.374881.241406.48-
Gross Margin
34.71%33.57%29.06%27.61%21.77%
Operating Margin
16.36%11.27%9.64%9.98%7.92%
Profit Margin
11.35%6.84%5.59%4.93%1.73%
Free Cash Flow Margin
7.10%5.23%22.01%5.88%21.39%
EBITDA
28,52616,29017,86319,75916,660
EBITDA Margin
19.16%15.22%16.11%16.52%16.27%
D&A For EBITDA
4,1784,2317,1717,8168,546
EBIT
24,34912,06010,69311,9428,113
EBIT Margin
16.36%11.27%9.64%9.98%7.92%
Effective Tax Rate
20.00%20.36%20.00%21.30%29.38%
Revenue as Reported
148,869107,036110,906119,634102,410
Source: S&P Global Market Intelligence. Standard template. Financial Sources.